Bio-Rad

The firm said the decline in revenues was primarily due to lower net sales in its life science business, though its clinical diagnostics sales also fell.

Vendors, kit makers, and service providers using dPCR are crafting diverse strategies to ramp up adoption of the technology.

Last week, readers were most interested in a story about how blood-based testing is making increasing inroads for neurological conditions.